What are the 16 theatres at the Festival of Genomics and Biodata London?

The 16 theatres at the Festival each explore a different area of genomics and biodata, from AI, multi-omics and rare disease to cancer, population health, and clinical genomics.

Can I attend sessions in multiple theatres?

Yes, attendees can freely explore sessions across all 16 theatres depending on their interests and schedule.

Are the theatre sessions included in my free ticket?

Yes, all theatre sessions are included as part of the Festival’s free ticket offering.

Explore 16 Theatres | Festival of Genomics & Biodata London

New for 2026: More Theatres, New Topics, Bold Thinking

The 2026 Festival introduces 3 brand-new theatres, designed to reflect the latest innovations in AI, healthcare and the life sciences landscape. Across all 16 theatres the content has been carefully curated to help you overcome the challenges that matter most to you.

The Festival is accompanied by hands-on workshops and interactive roundtables, so it’s easier than ever to meet like-minded people and join some of the most influential voices in the community, sharing cutting-edge insights and real-world solutions.

Following the Festival, in-person attendees will get on-demand access to all available session recordings where we have the speaker's permission to share them - typically over 90% of the sessions. Please note you have to attend the Festival to get access to the on-demand recordings.

The Innovation Stage highlights the advances in sequencing technologies.

Day 2 switches onto how these advances are accelerating the UK life science ecosystem for patient benefit – including policy updates, clinical trial enablement and accelerating patient access to the latest therapies.

Delve into the development of  large-scale research datasets and how these are being optimised.

You will hear about data infrastructure, storage, access and quality. 

Explore how cutting-edge single-cell technologies are transforming biological discovery. This stage will spotlight the power of single-cell analysis to reveal cellular heterogeneity, integrate multi-modal and spatial data, and deepen biological interpretation.

You’ll hear how AI is enhancing analytical precision, and how single-cell applications are driving breakthroughs across research and clinical settings.

This theatre focuses on leveraging the full spectrum of cancer omics to better diagnose and clinically profile cancer for better patient outcomes.

It will cover advances in liquid biopsy analysis, molecular profiling and precision oncology.

Day 1: Dedicated NHS showcase, on cutting-edge technologies being translated into clinical practice—through testing services, patient outcomes and integration. 

Day 2: Transformation programmes and evolving roles of specialists —including genetic counsellors, midwives and nurses. Discover how collaboration can drive change in genomic medicine. 

This theatre covers the use of AI for drug target ID and validation, data strategies for pharma, taking AI pilots beyond proof of concept and applying the latest AI models to support your drug pipeline.

AI in Healthcare Transformation Stage Icon 2

We’ll explore how AI can be seamlessly integrated into clinical workflows to improve decision-making, enhance patient care and drive system-wide innovation. Join us to discover strategies for breaking down data silos, aligning AI with real-world clinical contexts and building trust in AI-powered tools.

Welcome to the world of microbes! Dive into everything from microbiome research and its impact on human health, to pathogen detection, surveillance and strategies to overcome antimicrobial resistance.

This theatre covers how to tackle the integration of diverse omics datasets to better understand biological context, AI for multi-omics analysis and advance approaches for using omics in drug discovery.

Overcome challenges to generate meaningful clinical insights from large proteomics datasets, including single-cell and spatial proteomics, scaling clinical proteomics and advancing precision medicine using innovative proteomic technologies.

Dive into the latest developments in cell and gene therapies. From navigating the complexities of implementation to understanding patient impact. Discuss how advanced therapies are being delivered and scaled within the in the UK and Europe.

ONE WORLD GENOMICS & POPULATION HEALTH icon

Explore how epigenetics and emerging omics are advancing our understanding of gene regulation, disease mechanisms and environmental influences on health. This stage covers topics from cancer epigenetics to neurogenomics, highlighting innovative approaches to tackle biological complexity.

Unlock the potential of pharmacogenomics to drive smarter, more targeted drug development and clinical decision-making. This stage explores how genetic insights are enabling data-driven patient stratification, optimising trial design, and supporting the adoption of personalised therapies.

Explore patient engagement, inclusive innovation, and efforts to support under-represented populations.

On Day 2, the focus shifts to global collaboration, education and the promise of population genomics to improve health outcomes worldwide.

Explore conditions that affect the female reproductive system, such as ovarian cancer, endometriosis, and fertility challenges, alongside advancements in children’s health through pre-and-post-natal genomics, newborn screening and paediatric care.

This stage explores the integration of spatial technologies to reveal cellular dynamics, map molecular architecture, and profile complex tissue environments. You’ll hear how high-resolution spatial transcriptomics and proteomics are uncovering functional architecture, with powerful applications in areas like tumour microenvironment analysis and drug discovery.